R&D Systems™ Recombinant Human IL-12 R beta 2 Fc Chimera Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-12 R beta 2 Fc Chimera Protein is derived from NS0. The Recombinant Human IL-12 R beta 2 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q99665-1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3595
• Molecular Weight (g/mol): 95 kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human IL-12 R beta 2 protein, (N-terminus) Human IL-12 R beta 2 (Lys24-Asn622) Accession &Num; Q99665-1 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Storage Requirements: Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Cross Reactivity: IL-12 R beta 2
• Species: Human
• Reconstitution: Reconstitute at 250 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.